Life Science Company News

Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Currax Pharmaceuticals Moves Global Headquarters to Brentwood, Tennessee

Move Supports Company's Go-Forward Strategy to Accommodate Growth and Development in Tennessee, a Growing Hub for Biotech, Pharmaceutical and Healthcare Companies Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Emmes Announces New Role for the Blood and Marrow Transplant Clinical Trials Network

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Moonlight Therapeutics Awarded $1.9M Grant to Advance Development of Peanut Allergy Treatment

Moonlight Therapeutics, Inc., a biotechnology company developing treatments for food allergies, announced the receipt of $1.9 million in funding for preclinical studies and product development that will enable preparations for a clinical trial for its lead program in peanut allergy. This funding... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Leader in O2 Sensing Solutions Launch RAD-0002-ZR Low Oxygen Zirconia Monitor to Exceed Standards

Gaslab launches its new, wall-mounted safety device, the Low Oxygen Monitor, that adds new sensing capabilities Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Streamlining Brain Tumor Surgery Care During the Pandemic

Pacific Neuroscience Institute at Providence Saint John's strives to set new standard of safe, efficient, high quality minimally invasive brain tumor surgery during COVID-19 Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

New Book Helps Women Connect with Their Superpowers to Live Their Best Lives

Twenty-six women share their personal stories of resilience, hope and healing in Find Your Voice, Save Your Life 2 Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

ValGenesis Inc. Announces the Appointment of Kevin O'Donnell as Chief Financial Officer

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

GeneTex Develops Recombinant Influenza Nucleoprotein Antibodies as Potential Diagnostics

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Audeze and SMRT Image announce breakthrough headphones to improve patient comfort, and to support neuroscience research

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Texas Adds Endari® to Latest Preferred Drug List

Affords Easier Access to Medicaid Patients Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Femtech Market Revenue to Cross USD 65 Bn by 2027: Global Market Insights Inc.

The APAC femtech market will expand at more than 17% CAGR through 2027, led by the government initiatives and support to increase acceptance of digital platforms in health management and to broaden accessibility to remote areas. Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

DisperSol and Catalent Collaborate to Establish KinetiSol® Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline

DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management

- FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone[1] every minute with optional real-time glucose alarms[2];- The FreeStyle Libre 2 app enables kids (ages 4 and older) and adults to easily share their glucose... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Lupus Foundation of America Celebrates FDA Approval of Saphnelo™ (Anifrolumab-fnia) as a New Treatment for Lupus

This type I interferon receptor antagonist demonstrated early and sustained benefits for people with moderate to severe systemic lupus erythematosus. Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

SK Life Science, Inc. Launches STEPS Toward Zero Movement to Educate, Inspire and Activate the Epilepsy Community

Zero seizures is recognized as the optimal treatment goal for people with epilepsy, yet almost 40 percent of people with epilepsy continue to have seizures(1,2);STEPSTowardZero.com will offer new resources to support people with epilepsy in having candid conversations with their doctors in their... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Loyola University Chicago and Lyfebulb Announce Partnership Launch 2021 Innovation Challenge Call for Entries

A Total of $75,000 Will Be Distributed to Up to Three Finalists Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events

- Ionis-discovered pelacarsen continues to advance as potential first new therapy for Lp(a)-driven cardiovascular disease Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

MiRus Announces Appointment of Angela Coldwell as Chief Financial Officer

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Antidote Technologies' Business Development Leader Dave Mauro Named to the 2021 PharmaVOICE 100

Recognition highlights how Mauro's strategic sales management and operations expertise are leading Antidote to success Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate